Anzeige
Mehr »
Login
Montag, 20.09.2021 Börsentäglich über 12.000 News von 674 internationalen Medien
Neue Rekordfahrt? Die große Chance zu Wochenbeginn!?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0LEWB ISIN: FR0004186856 Ticker-Symbol: 8JM 
Frankfurt
20.09.21
08:07 Uhr
129,40 Euro
-3,20
-2,41 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
VETOQUINOL SA Chart 1 Jahr
5-Tage-Chart
VETOQUINOL SA 5-Tage-Chart
RealtimeGeldBriefZeit
129,40130,2011:53

Aktuelle News zur VETOQUINOL Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiVetoquinol: Veterinary Parasiticide Felpreva (tigolaner / emodepside / praziquantel) Receives Positive Opinion From European Committee for Medicinal Products for Veterinary Use (CVMP)142On approval, Felpreva will be licensed for treatment in cats with, or at risk from, mixed ectoparasite infestations and endoparasite infections, and will be exclusively indicated when ectoparasites...
► Artikel lesen
DiACHTUNG - KILL: Bitte ignorieren Sie den Text VETOQUINOL, vom 13 Sep 2021, mit der Überschrift Veterinärmedizinisches Parasitizid Felpreva (Tigolaner / Emodepsid / Praziquantel) erhält positive Stellungnahme vom Europäischen Ausschuss für...130ACHTUNG KILL: Bitte ignorieren Sie den Text VETOQUINOL, vom 13 Sep 2021, mit der Überschrift Veterinärmedizinisches Parasitizid Felpreva (Tigolaner Emodepsid Praziquantel) erhält positive Stellungnahme...
► Artikel lesen
13.09.Vetoquinol: Veterinärmedizinisches Parasitizid Felpreva (Tigolaner / Emodepsid / Praziquantel) erhält positive Stellungnahme vom Europäischen Ausschuss für Tierarzneimittel (CVMP)194Nach erfolgter Zulassung wird Felpreva für die Behandlung von Katzen mit gemischtem Ektoparasitenbefall und Endoparasiteninfektionen oder dem Risiko eines solchen Befalls lizenziert und ist ausschließlich...
► Artikel lesen
VETOQUINOL Aktie jetzt für 0€ handeln
13.09.Vetoquinol: Veterinary Parasiticide Felpreva (tigolaner / emodepside / praziquantel) Receives Positive Opinion From European Committee for Medicinal Products for Veterinary Use (CVMP)191On approval, Felpreva will be licensed for treatment in cats with, or at risk from, mixed ectoparasite infestations and endoparasite infections, and will be exclusively indicated when ectoparasites...
► Artikel lesen
29.07.VETOQUINOL ORD reports 1H results1
29.07.Vetoquinol: 2021 First Half Results215STRONG PERFORMANCE ACROSS THE BOARD First half sales: €255m (up 33.5% at constant exchange rates) Essentials sales: €143m (up 45.2% at constant exchange rates) EBIT before depreciation of acquired...
► Artikel lesen
28.04.Vetoquinol: Availability of the 2020 Universal Registration Document309Regulatory News: Vetoquinol (Paris:VETO) informs that it has filed its 2020 Universal Registration Document with the Autorité des Marchés Financiers (AMF) on April 28th, 2021. The 2020 Universal...
► Artikel lesen
16.04.XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 16.04.2021794The following instruments on XETRA do have their first trading 16.04.2021 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag am 16.04.2021 Aktien 1 US34960Q2084 Fortress Biotech...
► Artikel lesen
15.04.Vetoquinol: Q1 2021 Sales: €128M299(UP 28% AT CONSTANT EXCHANGE RATES, UP 24% AS REPORTED) Q1 2021 ESSENTIALS SALES: €72.6M (UP 38% AT CONSTANT EXCHANGE RATES, UP 36% AS REPORTED) Regulatory News: Vetoquinol (Paris:VETO): ...
► Artikel lesen
01.04.VETOQUINOL ORD reports FY results-
01.04.Vetoquinol: VETOQUINOL 2020 ANNUAL RESULTS2922020 sales: €427.5m (up 8.0% as reported) EBIT before depreciation of assets arising from acquisitions: €65.3m (up 33.5%) Net income Group share: €19.2m (4.5% of sales) Cash flow:...
► Artikel lesen
08.02.Vetoquinol Acquires the Rights for Profender from Elanco Animal Health for Canada424Regulatory News: Vetoquinol (Paris:VETO) announced today the acquisition of the Canadian rights to Profender product family from Elanco Animal Health. Vetoquinol has acquired the Profender product...
► Artikel lesen
21.01.Vetoquinol 2020 Sales: €427.5M (up 8.0% as Reported, up 10.9% at Constant Exchange Rate) Essentials Sales: €220.6M (up 15.7% as Reported, up 17.3% at Constant Exchange Rate)301Regulatory News: Vetoquinol (Paris:VETO) CEO Matthieu Frechin said: "2020 was an exceptional year on a number of counts. Above all, it is important to pay tribute to our teams, whose hard work...
► Artikel lesen
18.01.VETOQUINOL: Orion Animal Health and Vetoquinol Expand Collaboration - Vetoquinol to Distribute Orion's Clevor in the USA and Orion to Distribute Drontal and Profender Products in Finland, Hungary and Romania499Orion Animal Health and Vetoquinol are expanding their collaboration with new distribution agreements. The U.S. Food and Drug Administration FDA granted approval for Orion's Clevor, an eye drop...
► Artikel lesen
11.01.Vetoquinol Acquires the Rights for Drontal and Profender Families from Elanco Animal Health for Australia431Regulatory News: Vetoquinol (Paris:VETO) announced today the acquisition of the Australian rights to Drontal and Profender product families from Elanco Animal Health. Vetoquinol has acquired...
► Artikel lesen
15.12.20Vetoquinol: 2021 Calendar of Financial Communication363Regulatory News: Vetoquinol (Paris:VETO) published its calendar of financial communication for 2021. January 21, 2021 2020 Annual revenues (after market) April...
► Artikel lesen
15.10.20Vetoquinol: Q3 2020 Sales: €114.5 Million* (up 14.3%)326Regulatory News: Vetoquinol (Paris:VETO) posted sales of €114.5 million for the third quarter of 2020, up 14.3% as reported compared to the same period last year. All Vetoquinol territories posted...
► Artikel lesen
17 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1